Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Heron Therapeutics, Inc. (HRTX) had Weighted-Average Shares Outstanding (Basic) of 166.71M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$154.90M |
|
$-20.20M |
|
$41.35M |
|
$113.56M |
|
$157.44M |
|
$-2.54M |
|
$-17.66M |
|
$-20.20M |
|
$-20.20M |
|
$-20.20M |
|
$-20.20M |
|
$-20.20M |
|
$-20.20M |
|
$-2.54M |
|
$-0.15M |
|
|
Weighted-Average Shares Outstanding (Basic) |
166.71M |
166.71M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$238.07M |
|
$12.40M |
|
$17.81M |
|
$255.88M |
|
$96.10M |
|
$140.64M |
|
$145.45M |
|
$241.54M |
|
$13.28M |
|
$14.33M |
|
$14.33M |
|
188.31M |
|
| Cash Flow Statement Financials | |
$-27.59M |
|
$16.01M |
|
$14.43M |
|
$25.80M |
|
$28.65M |
|
$2.85M |
|
$10.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.48 |
|
-- |
|
-- |
|
0.91 |
|
9.81 |
|
73.31% |
|
-1.64% |
|
-1.64% |
|
-0.09% |
|
-13.04% |
|
-13.04% |
|
$-27.81M |
|
-- |
|
-- |
|
-- |
|
0.61 |
|
0.45 |
|
1.73 |
|
211.09 |
|
-152.03% |
|
-140.90% |
|
-7.89% |
|
-13.03% |
|
$0.08 |
|
$-0.17 |
|
$-0.17 |
|